AURINIA PHARMACEUTICALS INC.
AURINIA PHARMACEUTICALS INC.
EDMONTON, AB
Loading...
Price History
Market Data
| Market Cap | 2.12B |
| P/E Ratio | 7.72 |
| P/B Ratio | 3.65 |
| EPS | 2.07 |
| Dividend Yield | - |
| D/E Ratio | 0.29 |
| Current Ratio | 5.25 |
| Currency | USD |
Key Financial Metrics
283.06M
Revenue
287.20M
Net Income
2.07
EPS (Diluted)
182.50M
Free Cash Flow
Profitability
Gross Margin
88.5%
Operating Margin
37.1%
Net Profit Margin
101.5%
EBITDA
138.94M
Returns & Efficiency
Return on Assets (ROA)
38.2%
Return on Equity (ROE)
49.4%
Dividend Yield
-
EPS
2.07
Financial Health
Total Assets
751.59M
Total Debt
-
Debt to Equity
0.29x
Current Ratio
5.25
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | EDMONTON, AB |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$2.12B
P/E Ratio (TTM)7.7
Price to Book3.65
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin88.5%
Operating Margin37.1%
Net Margin101.5%
ROE49.4%
ROA38.2%
Leverage & Liquidity
Debt to Equity0.29
Current Ratio5.25
Total Debt-
Total Assets$751.59M
Stockholders' Equity$581.33M
Income Statement (FY 2025)
Revenue$283.06M
Gross Profit$250.39M
Operating Income$104.91M
Net Income$287.20M
EPS (Diluted)$2.07
Cash Flow (FY 2025)
Free Cash Flow$182.50M
Cash & Equivalents$80.16M
Revenue Growth20.4%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | #140, 14315 - 118 AVENUE EDMONTON, AB T5L 4S6 |
| Phone | 250-744-2487 |
| Incorporated | None, None |
| EIN | 981231763 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 132.97M |
| Stockholders' Equity | $581.33M |
| Cash & Equivalents | $80.16M |
Recent Filings
View All
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-21
Local
SC TO-T
SC TO-T Filing
SEC regulatory filing
Filed: 2026-04-13
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-03-25
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | AURINIA PHARMACEUTICALS INC. |
| Ticker | AUPH |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | EDMONTON, AB |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 2.12B |
| Revenue | 283.06M |
| Net Income | 287.20M |
| P/E Ratio | 7.72 |
| EPS | 2.07 |
| Net Margin | 101.5% |
| ROE | 49.4% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...